Dystonia has been described as a potential toxicity of radiation therapy. Management of this rare movement disorder is targeted in symptom improvement. We report a case of a 46-year-old female patient who developed dystonia during treatment of melanoma metastatic to the brain and discuss potential causes of and therapies for this rare complication.
|Original language||English (US)|
|Number of pages||6|
|Journal||Case Reports in Oncology|
|State||Published - Jan 2013|
- Brain metastasis
- Gamma Knife therapy
- High-dose interleukin-2